推薦產品
品質等級
形狀
powder
存貨情形
not available in USA
標籤範圍
0.60-0.95 substitution
損耗
≤15% loss on drying, 110 °C
顏色
light yellow
pH值
6.5-8.0 (10 mg/mL in H2O)
黏度
300-1000 mPa.s, 2 % in H2O(25 °C) (dry substance)
mp
> 300.05 °C ((> 572.09 °F ))
InChI
1S/C6H12O6.C2H4O2.Na/c7-1-3(9)5(11)6(12)4(10)2-8;1-2(3)4;/h1,3-6,8-12H,2H2;1H3,(H,3,4);
InChI 密鑰
DPXJVFZANSGRMM-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
R Macarrón et al.
The Biochemical journal, 289 ( Pt 3), 867-873 (1993-02-01)
Endoglucanase III (EG III) was purified to homogeneity from the culture medium of Trichoderma reesei QM 9414. It has a molecular mass of 48 kDa, and an isoelectric point of 5.1. Maximal activity was observed between pH4 and 5. Celloligosaccharides
Babak Ghanbarzadeh et al.
International journal of biological macromolecules, 48(1), 44-49 (2010-10-06)
Glycerol and oleic acid (OA) were incorporated into carboxymethyl cellulose (CMC) films by an emulsification method. Films containing different amounts of glycerol and OA were examined for mechanical properties, water vapor permeability (WVP), and moisture uptake, optical and thermal properties.
Lihua Cheng et al.
PloS one, 6(9), e25433-e25433 (2011-10-04)
Cisplatin is a potent anticancer drug, but its clinical application has been limited due to its undesirable physicochemical characteristics and severe side effects. Better drug formulations for cisplatin are highly desired. Herein, we have developed a nanoparticle formulation for cisplatin
Georg Geisberger et al.
Small (Weinheim an der Bergstrasse, Germany), 7(19), 2808-2814 (2011-09-29)
Polyoxometalate/carboxymethyl chitosan nanocomposites with an average diameter of 130 nm are synthesized and labeled with fluorescein isothiocyanate (FITC) for a combined drug-carrier and cellular-monitoring approach. [Eu(β(2) -SiW(11) O(39) )(2) ](13-) /CMC nanospheres as a representative example do not display cytotoxicity
Gunnar M Buyse et al.
European heart journal, 30(1), 116-124 (2008-09-12)
Duchenne muscular dystrophy (DMD) is a severe and still incurable disease, with heart failure as a leading cause of death. The identification of a disease-modifying therapy may require early-initiated and long-term administration, but such type of therapeutic trial is not
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務